Publications

  1. Zong P, Li C, Feng J, Yue Z, Legere N, Yu AS, Shah F, Perez A, Li Z, Jellison E, Mori Y, Miller B, Verma R, Liang B, Yue L. TRPM2 overactivation drives hyperlipidemia-induced dysfunction of myeloid cells and neurovascular units. Cell Rep Med. 2025 Mar 3:101998. doi: 10.1016/j.xcrm.2025.101998. Epub ahead of print. PMID: 40056905.
  2. Yadav SK, Dhuri K, Gamiotea-Turro D, Cormier MK, Patel V, Yadawa AK, Pathuri M, Bahal R, Verma R*. Exploring the therapeutic potential of sγPNA-141: Pharmacodynamics and mechanistic insights during ischemic stroke recovery. Molecular Therapy Nucleic Acids. 2024 Oct 9;35(4):102355. doi: 10.1016/j.omtn.2024.102355. PMID: 39507400; PMCID: PMC11539414.
  3. Gamiotea-Turro D, Cronin CG, Yadav SK, Yadawa AK, Cormier MK, Liang BT, Verma R*. Revealing the Novel Role of Purinergic Receptor P2X4 in Phagocytic Uptake After Ischemic Stroke. Journal of American Heart Association. 2024 Oct;13(19):e037148. doi: 10.1161/JAHA.124.037148. Epub 2024 Sep 30. PMID: 39344649; PMCID: PMC11681490.
  4. Atomwise AIMS Program. AI is a viable alternative to high throughput screening: a 318-target study. Sci Rep. 2024 Apr 2;14(1):7526. doi: 10.1038/s41598-024-54655-z. Erratum in: Sci Rep. 2024 Sep 16;14(1):21579. doi: 10.1038/s41598-024-70321-w. PMID: 38565852; PMCID: PMC10987645..
  5. Ghosh M, McGurk F, Norris R, Dong A, Nair S, Jellison E, Murphy P, Verma R, Shapiro LH. The Implant-Induced Foreign Body Response Is Limited by CD13-Dependent Regulation of Ubiquitination of Fusogenic Proteins. Journal Immunology. 2023 Dec 27:ji2300688. doi: 10.4049/jimmunol.2300688. Epub ahead of print. PMID: 38149920.
  6. Chaudhary R, Rehman M, Agarwal V, Kumar A, Kaushik AS, Srivastava S, Srivastava S, Verma R, Rajinikanth PS, Mishra V. Terra incognita of glial cell dynamics in the etiology of leukodystrophies: Broadening disease and therapeutic perspectives. Life Sci. 2024 Oct 1;354:122953. doi: 10.1016/j.lfs.2024.122953. Epub 2024 Aug 8. PMID: 39122110.
  7. Arul MR, Alahmadi I, Turro DG, Ruikar A, Abdulmalik S, Williams JT, Sanganahalli BG, Liang BT, Verma R*, Kumbar SG. Fluorescent liposomal nanocarriers for targeted drug delivery in ischemic stroke therapy. Biomaterial Sciences. 2023 Dec 5;11(24):7856-7866. doi: 10.1039/d3bm00951c. PMID: 37902365; PMCID: PMC10697427.
  8. Gamiotea-Turro D, Cronin CC, Liang BT, Verma R*. Transcriptomic analysis reveals novel age-independent immunomodulatory proteins as a mode of cerebroprotection in P2X4 receptor knockout mice after ischemic stroke. Purinergic Signaling. 2023 Sep;19(3):489-500. doi: 10.1007/s11302-023-09956-9. Epub 2023 Jul 13. PMID: 37439999; PMCID: PMC10539265.
  9. Toti KS, Verma R, McGonnigle MJ, Gamiotea Turro D, Wen Z, Lewicki SA, Liang BT, Jacobson KA. Structure-Activity Relationship and Neuroprotective Activity of 1,5-Dihydro-2H-naphtho[1,2-b][1,4]diazepine-2,4(3H)-diones as P2X4 Receptor Antagonists. J Med Chem. 2022 Oct 27;65(20):13967-13987. doi: 10.1021/acs.jmedchem.2c01197. Epub 2022 Sep 23. PMID: 36150180; PMCID: PMC9653265.
  10. Paro MR, Chakraborty AR, Angelo S, Nambiar S, Bulsara KR, Verma R*. Molecular mediators of angiogenesis and neurogenesis after ischemic stroke. Rev Neurosci. 2022 Sep 8. doi: 10.1515/revneuro-2022-0049. Epub ahead of print. PMID: 36073599.
  11. Paro MR, Gamiotea Turro D, Mcgonnigle M, Bulsara KR, Verma R*. A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice. J Vis Exp. 2022 Jun 22;(184). doi: 10.3791/63951. PMID: 35815995.
  12. Dhuri K, Vyas R, Blumenfeld L, Verma R*, Bahal R. Nanoparticle Delivered Anti-miR-141-3p for Stroke Therapy. Cells 2021, 10(5), 1011; https://doi.org/10.3390/cells10051011
  13. Srivastava P, Cronin CG, Scranton VL, Jacobson KA, Liang BT, Verma R*. Neuroprotective and neuro-rehabilitative effects of acute purinergic receptor P2X4 (P2X4R) blockade after ischemic stroke. Exp Neurol. 2020 Jul; 329:113308. doi: 10.1016/j.expneurol.2020.113308. Epub 2020 Apr 11. PubMed PMID: 32289314; PubMed Central PMCID: PMC7242087.
  14. Patrizz A, Doran SJ, Chauhan A, Ahnstedt H, Roy-O'Reilly M, Lai YJ, Weston G, Tarabishy S, Patel AR, Verma R, Staff I, Kofler JK, Li J, Liu F, Ritzel RM, McCullough LD. EMMPRIN/CD147 plays a detrimental role in clinical and experimental ischemic stroke. Aging (Albany NY). 2020 Mar 19;12(6):5121-5139. doi: 10.18632/aging.102935. Epub 2020 Mar 19. PubMed PMID: 32191628; PubMed Central PMCID: PMC7138568.

http://www.ncbi.nlm.nih.gov/myncbi/1pMGjK8l8VkA5/bibliography/47933112/public/?sort=date&direction=ascending